Seeking Alpha

Second phase of ADVANTAGE AF study of FARAPULSE™ Pulsed Field Ablation System meets primary safety and efficacy endpoints

MARLBOROUGH, Mass. and SAN DIEGO, April 24, 2025 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced positive 12-month primary endpoint results from the second phase of the ...
Medscape

FDA: AF Catheter-Ablation System Benefit Doesn't Outweigh Risk

October 28, 2011 (Rockville, Maryland) — For the second day in a row, the Food and Drug Administration's Circulatory System Devices advisory panel debated and discussed data related to another device ...
Healio

FDA approves first pulsed field AF ablation system

Please provide your email address to receive an email when new articles are posted on . The FDA approved the first pulsed field ablation system for the treatment of paroxysmal and persistent AF. The ...
Healio

FDA approves mapping, dual-energy catheter ablation system for persistent AF

Please provide your email address to receive an email when new articles are posted on . The FDA approved a mapping and dual-energy catheter ablation system for treatment of persistent AF. The system ...
TCTMD

CardioFocus' HeartLight® System Granted FDA Approval for Treatment of Atrial Fibrillation (AF)

MARLBOROUGH, Mass., CardioFocus, Inc. today announced that it has received premarket approval (PMA) from the U.S. Food and Drug Administration (FDA) for its HeartLight® Endoscopic Ablation System for ...
Forbes

TTOP-AF Trial Demonstrates Efficacy of RF Ablation System, But Fails To Prove Safety

A new trial demonstrates that an investigational RF ablation system is more effective than medical management in treating persistent AF, but the trial failed to meet a key predefined safety goal. At ...
Medscape

FDA Approves First Pulsed Field Ablation System for AF

The US Food and Drug Administration (FDA) has approved the PulseSelect Pulsed Field Ablation (PFA) System (Medtronic) for the treatment of both paroxysmal and persistent atrial fibrillation (AF), the ...